This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Novartis Ag. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Manfred Müller - Innovator in Inhalation Technology
Introduction
Manfred Müller is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of inhalation technology, particularly through his innovative designs that enhance the delivery of therapeutic formulations.
Latest Patents
Müller's most recent patent is titled "Inhaler adapted to read information stored in data storage means of a container." This invention relates to an inhaler designed to supply a formulation contained within a container to a user. The inhaler is equipped to read information stored in the data storage means of the container. The system comprises both the inhaler and the container, which includes the formulation and the data storage means. The container is specifically designed for use in an inhaler, facilitating effective inhalation therapy. This patent highlights Müller's commitment to improving patient care through advanced technology.
Career Highlights
Manfred Müller is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to focus on developing innovative solutions that address the needs of patients requiring inhalation therapy. His dedication to research and development has positioned him as a key player in the field.
Collaborations
Müller has collaborated with several talented individuals in his field, including Dominik Ziegler and Richard Pavkov. These collaborations have fostered an environment of innovation and creativity, leading to advancements in inhalation technology.
Conclusion
Manfred Müller is a distinguished inventor whose work in inhalation technology has the potential to transform patient experiences. His innovative patent and contributions to Novartis AG underscore his commitment to enhancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
